Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
No peer-reviewed clinical studies, pharmacokinetic interaction data, or regulatory guidance exist on the combined use of AOD 9604 and retatrutide
Hsieh, M
Gallbladder events : As with other incretin-based therapies, there is a potential risk of gallbladder disease, including cholelithiasis (gallstones)
B12 is a water-soluble vitamin with excess readily excreted, making toxicity virtually unknown in elderly patients
(2013) Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans J Endocrinol Metab 3(12):715 AOD9604 vs Related GH-Axis Research Tools AOD9604s unique combination of GH receptor independence, direct lipolytic activity, absence of IGF-1 stimulation, and confirmed oral bioavailability makes it an irreplaceable research tool for studying adipose tissue metabolism and lipolysis without the systemic endocrine confounds associated with intact hGH or indirect GH secretagogues
